These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27580748)

  • 1. Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.
    Miller WR; Bayer AS; Arias CA
    Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27580748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR; Yim J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
    Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G; Derbentli S
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and risk factors of methicillin-resistant
    Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
    Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
    Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
    Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
    Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
    Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
    Singh KV; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32122892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
    Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
    Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
    Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycyclic Polyprenylated Acylphloroglucinols: An Emerging Class of Non-Peptide-Based MRSA- and VRE-Active Antibiotics.
    Guttroff C; Baykal A; Wang H; Popella P; Kraus F; Biber N; Krauss S; Götz F; Plietker B
    Angew Chem Int Ed Engl; 2017 Dec; 56(50):15852-15856. PubMed ID: 28985019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates.
    Bertsche U; Yang SJ; Kuehner D; Wanner S; Mishra NN; Roth T; Nega M; Schneider A; Mayer C; Grau T; Bayer AS; Weidenmaier C
    PLoS One; 2013; 8(6):e67398. PubMed ID: 23785522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
    Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii.
    Sakoulas G; Rose W; Berti A; Olson J; Munguia J; Nonejuie P; Sakoulas E; Rybak MJ; Pogliano J; Nizet V
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.
    Mishra NN; Yang SJ; Chen L; Muller C; Saleh-Mghir A; Kuhn S; Peschel A; Yeaman MR; Nast CC; Kreiswirth BN; Crémieux AC; Bayer AS
    PLoS One; 2013; 8(8):e71151. PubMed ID: 23990934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
    Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
    Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):412-6. PubMed ID: 21546202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elasnin Effectively Eradicates Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Biofilms.
    Sulaiman JE; Long L; Qian PY; Lam H
    Microbiol Spectr; 2022 Feb; 10(1):e0232021. PubMed ID: 35196789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.